ShoemarkA, GoutakiM, KinghornB, et al.European respiratory society and american thoracic society guidelines for the diagnosis of primary ciliary dyskinesia. Eur Respir J, 2025; 66(6):2500745; doi: 10.1183/13993003.00745-2025
2.
SchofieldLM, DuffA, BrennanC. Airway clearance techniques for primary ciliary dyskinesia: Is the Cystic Fibrosis literature portable? Paediatr Respir Rev, 2018; 25:73–77; doi: 10.1016/j.prrv.2017.03.011
3.
HannahWB, SeifertBA, TrutyR, et al.The global prevalence and ethnic heterogeneity of primary ciliary dyskinesia gene variants: a genetic database analysis. Lancet Respir Med, 2022; 10(5):459–468; doi: 10.1016/S2213-2600(21)00453-7
4.
GastonB, SmithLA, DavisMD, et al.Antigen stasis and airway nitrosative stress in human primary ciliary dyskinesia. Am J Physiol Lung Cell Mol Physiol, 2024; 326(4):L468–L476; doi: 10.1152/ajplung.00208.2022
5.
ShapiroAJ, DellSD, GastonB, et al.Nasal nitric oxide measurement in primary ciliary dyskinesia. A technical paper on standardized testing protocols. Ann Am Thorac Soc, 2020; 17(2):e1–e12; doi: 10.1513/AnnalsATS.201904-347OT
6.
Marangu-BooreD, LucasJS, BeydonN. Nasal nitric oxide measurement for the diagnosis of primary ciliary dyskinesia: summary of the European Respiratory Society technical standard. Breathe (Sheff), 2025; 21(2):240230; doi: 10.1183/20734735.0230-2024
7.
LevineH, TsvibanL, GoldbergO, et al.Impact of seasonal variability in nasal nitric oxide measurements for primary ciliary dyskinesia screening. Respir Care, 2026; 71(2):131–138; doi: 10.1177/19433654251378049
